Nikko Asset Management Americas Inc. 13D and 13G filings for Arcturus Therapeutics Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 3:17 pm Purchase | 2024-09-30 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Nikko Asset Management Americas Inc. | 2,315,294 8.560% | 994,642 (+75.31%) | Filing |
| 2024-02-12 6:09 pm Sale | 2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Nikko Asset Management Americas Inc. | 1,320,652 4.940% | -128,408 (-8.86%) | Filing |
| 2023-02-10 10:29 am Purchase | 2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Nikko Asset Management Americas Inc. | 1,449,060 5.450% | 91,588 (+6.75%) | Filing |
| 2022-02-14 06:04 am Purchase | 2021-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Nikko Asset Management Americas Inc. | 1,357,472 5.150% | 1,357,472 (New Position) | Filing |